Discover
NRIX
Nurix Therapeutics, Inc.
23.91
2 x 17.77
2 x 30.69
bid
ask
-
0.35
1.44%
2 @ 04:01 AM
23.84 -0.07 (0.29%)
| Ytd | 26.04% | |
| 1y | 104.18% |
23.76
day range
24.81
8.20
52 week range
24.88
| Open | 24.61 | Prev Close | 24.26 | Low | 23.76 | High | 24.81 | Mkt Cap | 2.47B |
| Vol | 1.13M | Avg Vol | 1.99M | EPS | -3.17 | P/E | N/A | Forward P/E | -9.08 |
| Beta | 1.87 | Short Ratio | 7.15 | Inst. Own | 114.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-09 | 50-d Avg | 17.37 | 200-d Avg | 15.58 | 1yr Est | 31.44 |
| Income Statement | |||
| Total Revenue | 6.25M | ||
| Revenues (USD) | 6.25M | ||
| Gross Profit | 6.25M | ||
| Operating Expenses | 98.75M | ||
| Research and Development Expense | 84.14M | ||
| Selling, General and Administrative Expense | 14.61M | ||
| Operating Income | -92.49M | ||
| Net Income | -87.17M | ||
| Net Income Common Stock | -87.17M | ||
| Net Income Common Stock (USD) | -87.17M | ||
| Consolidated Income | -87.17M | ||
| Earnings per Basic Share | -0.79 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -0.79 | ||
| Earning Before Interest & Taxes (EBIT) | -87.17M | ||
| Earning Before Interest & Taxes (USD) | -87.17M | ||
| Weighted Average Shares | 110.07M | ||
| Weighted Average Shares Diluted | 110.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 72.16M | ||
| Cash and Equivalents (USD) | 72.16M | ||
| Investments | 469.54M | ||
| Investments Current | 469.54M | ||
| Current Assets | 554.39M | ||
| Property, Plant & Equipment Net | 73.35M | ||
| Total Assets | 636.13M | ||
| Debt Current | 3.20M | ||
| Total Debt | 58.66M | ||
| Current Liabilities | 92.20M | ||
| Debt Non-Current | 55.45M | ||
| Total Liabilities | 155.24M | ||
| Accumulated Retained Earnings (Deficit) | -1.09B | ||
| Accumulated Other Comprehensive Income | 56.00K | ||
| Shareholders Equity | 480.89M | ||
| Shareholders Equity (USD) | 480.89M | ||
| Assets Non-Current | 81.74M | ||
| Total Debt (USD) | 58.66M | ||
| Deferred Revenue | 26.34M | ||
| Liabilities Non-Current | 63.04M | ||
| Trade and Non-Trade Payables | 10.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.78M | ||
| Net Cash Flow from Financing | 19.98M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -175.76M | ||
| Capital Expenditure | -1.04M | ||
| Issuance (Purchase) of Equity Shares | 19.98M | ||
| Net Cash Flow from Investing | -123.83M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -122.78M | ||
| Net Cash Flow from Operations | -71.91M | ||
| Share Based Compensation | 9.40M | ||